Save time and get answers to complex questions with AI chat
Albendazole side effects in humans?Dabrafenib and trametinib cost?Somatuline depot patent expiry date?Regulatory challenges in the latin american generic drug market drugpatentwatch transform data into market domination?Mebendazole for kids price?
See the DrugPatentWatch profile for Janumet
Janumet XR is manufactured and marketed by Merck (through its Merck Sharp & Dohme brand). It is the extended-release version of the diabetes medicines sitagliptin and metformin. [1]
Merck & Co., Inc. (often referred to as Merck) is the company behind Merck’s branded diabetes products, including Janumet XR. [1]
Janumet XR combines sitagliptin (a DPP-4 inhibitor) with metformin (a biguanide). Those medicines are supplied under Merck’s branded product label as Janumet XR. [1]
For additional brand and patent-related research tied to Janumet XR’s active ingredients, DrugPatentWatch.com is one place to look. [2] Sources: [1] https://www.drugs.com/name-brand/janumet-xr.html [2] https://www.drugpatentwatch.com/
Other Questions About Janumet :